News | September 05, 2024
Emcure Pharmaceuticals launches solution for menopause wellness ‘Arth’ in India
Effective, holistic, science-backed targeted solutions for symptomatic treatment
Effective, holistic, science-backed targeted solutions for symptomatic treatment
Presidential Symposium for NIAGARA will highlight practice-changing impact of a perioperative Imfinzi-based regimen in bladder cancer
ForDoz Pharma Corporation, USA (ForDoz) received an approval for its ANDA from the USFDA
First patient enrolled in the Phase III SOHO-02 trial of investigational agent BAY 2927088 in treatment-naïve patients with advanced NSCLC with HER2-activating mutations
The low-profile, 2” Disc Top Lite closure offers lighter weight combined with premium customization options
Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
This product will be manufactured by Indoco at its manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa in India
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
The clinical trial will be conducted at 19 sites with 10,335 participants across India
Subscribe To Our Newsletter & Stay Updated
